Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000579771 | SCV000685213 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-12-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000579771 | SCV001173203 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-02-27 | criteria provided, single submitter | clinical testing | The p.T563S variant (also known as c.1688C>G), located in coding exon 4 of the MSH6 gene, results from a C to G substitution at nucleotide position 1688. The threonine at codon 563 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001296048 | SCV001485003 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2022-09-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003465292 | SCV004195597 | uncertain significance | Endometrial carcinoma | 2023-08-11 | criteria provided, single submitter | clinical testing |